Tregalizumab (Synonyms: BT-061) |
| Catalog No.GC70057 |
Tregalizumab est un anticorps monoclonal humanisé anti-CD4 humain (de type IgG1) qui active sélectivement les propriétés inhibitrices des cellules T régulatrices (Tregs) in vitro. Le Tregalizumab peut être utilisé dans la recherche sur les maladies auto-immunes (causées par une insuffisance d'activité des Tregs) et les allergies.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1207446-68-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Tregalizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Tregalizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *